 |
|
Can Dermatopathologists Reliably Make the Diagnosis of Mycosis Fungoides?
If Not, Who Can?
Arch Dermatol. 2000;136:543-546.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
CONSIDER A 50-year-old man. For perhaps 10 or 15 years he has had slightly scaling, pink patches on his trunk. He brought these to the attention of his internist, who told him that they most likely represented eczema and prescribed a cream that contained both steroids and an antifungal agent. The patches improved slightly at times, but never went away entirely. One day, he visits a dermatologist because he has an unusual-appearing mole on his back. The dermatologist inquires about the patches and, after hearing his story, is concerned enough to perform a biopsy. Being of an inquisitive mind (with full disclosure and approval from every ethics committee imaginable), she performs several dozen biopsies on him. She sends some of the specimens to a dermatopathology laboratory, some to the general pathologists at the local hospital, some to a hematopathologist at the university hospital she is associated with, and some to . . . [Full Text of this Article]
RELATED ARTICLE
Accuracy, Concordance, and Reproducibility of Histologic Diagnosis in Cutaneous T-Cell Lymphoma: An EORTC Cutaneous Lymphoma Project Group Study
Marco Santucci, Annibale Biggeri, Alfred C. Feller, Günter Burg, and for the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group
Arch Dermatol. 2000;136(4):497-502.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Lymphoproliferative lesions of the skin.
Cerroni
J. Clin. Pathol. 2006;59:813-826.
ABSTRACT
| FULL TEXT
Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma
Duvic et al.
Arch Dermatol 2001;137:581-593.
ABSTRACT
| FULL TEXT
|
